ghk cu sermorelin (GHRH 1-29) Sermorelin Peptide Therapy: Reboot Your

Clinical research has shown BPC-157s benefits for mental, gastrointestinal, cardiac, and autoimmune health

Clinical Benefits (Evidence-Based): Increased lean muscle mass (average 4-6% improvement in studies) Reduced body fat, particularly abdominal fat (8-12% reduction) Improved sleep quality and deeper REM cycles Enhanced recovery from exercise and injury Better skin elasticity and reduced wrinkles Improved bone density markers Enhanced cognitive function and mental clarity Dosing Protocols: Typically administered subcutaneously before bed, 5-7 days per week

the exact window depends on the product and diluent

clinics must handle GHK-Cu injections with extra caution